Titan Pharmaceuticals Inc. (NASDAQ: TTNP)
$3.8750
+0.1650 ( +4.73% ) 8.8K
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
Market Data
Open
$3.8750
Previous close
$3.7100
Volume
8.8K
Market cap
$3.58M
Day range
$3.7100 - $3.9400
52 week range
$3.5100 - $14.8000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 74 | Apr 01, 2024 |
8-k | 8K-related | 13 | Apr 01, 2024 |
4 | Insider transactions | 1 | Mar 27, 2024 |
8-k | 8K-related | 13 | Mar 21, 2024 |
8-k | 8K-related | 14 | Feb 08, 2024 |
8-k | 8K-related | 12 | Jan 25, 2024 |
8-k | 8K-related | 12 | Jan 18, 2024 |
8-k | 8K-related | 13 | Jan 08, 2024 |
8-k | 8K-related | 14 | Dec 28, 2023 |
def | Proxies and info statements | 1 | Nov 28, 2023 |